I feel good! Gender differences and reporting heterogeneity in self-assessed health

The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
Udo SchneiderVolker Ulrich

Abstract

For empirical analysis and policy-oriented recommendations, the precise measurement of individual health or well-being is essential. The difficulty is that the answer may depend on individual reporting behaviour. Moreover, if an individual's health perception varies with certain attitudes of the respondent, reporting heterogeneity may lead to index or cut-point shifts of the health distribution, causing estimation problems. An index shift is a parallel shift in the thresholds of the underlying distribution of health categories. In contrast, a cut-point shift means that the relative position of the thresholds changes, implying different response behaviour. Our paper aims to detect how socioeconomic determinants and health experiences influence the individual valuation of health. We analyse the reporting behaviour of individuals on their self-assessed health status, a five-point categorical variable. Using German panel data, we control for observed heterogeneity in the categorical health variable as well as unobserved individual heterogeneity in the panel estimation. In the empirical analysis, we find strong evidence for cut-point shifts. Our estimation results show different impacts of socioeconomic and health-related variables ...Continue Reading

References

May 1, 1995·Health Economics·M Kerkhofs, M Lindeboom
Feb 5, 2003·Journal of Health Economics·Eddy van Doorslaer, Andrew M Jones
Nov 24, 2004·Journal of Health Economics·Maarten Lindeboom, Eddy van Doorslaer
May 9, 2006·Journal of Health Economics·Richard DisneyMatthew Wakefield
Sep 8, 2006·Health Economics·Fabrice Etilé, Carine Milcent
Aug 19, 2007·Health Economics·Teresa Bago d'UvaOwen O'Donnell
Apr 27, 2010·Social Science & Medicine·Nicolas Ziebarth

❮ Previous
Next ❯

Citations

Mar 27, 2012·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Joachim R Frick, Nicolas R Ziebarth
Jul 21, 2012·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Fredrik Odegaard, Pontus Roos
Oct 6, 2012·Health Economics Review·Christian PfarrUdo Schneider
Feb 28, 2016·Social Science & Medicine·Eve Caroli, Lexane Weber-Baghdiguian
Jan 11, 2016·Health Economics·Daniel Kuehnle, Christoph Wunder
Sep 23, 2016·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Silke AurasMax Geraedts
Jun 18, 2015·Cadernos de saúde pública·Susana Cararo ConfortinEleonora d'Orsi
Feb 2, 2017·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Amelie F ConstantTzahi Neuman
Aug 11, 2019·BMC Public Health·Fernando Fajardo-BullónLars Benjaminsen
Jun 20, 2019·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Valerie AndreesJanine Topp
Jan 29, 2020·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Sonja Spitzer
Feb 16, 2020·International Journal of Health Economics and Management·Aida Isabel Tavares, Pedro Lopes Ferreira
Dec 4, 2019·The International Journal of Health Planning and Management·Aida Isabel Tavares
Jan 17, 2021·Journal of Epidemiology and Community Health·João Vasco SantosAlberto Freitas
Dec 6, 2020·International Journal of Environmental Research and Public Health·Fernando Fajardo-BullónMarcus Knutagård
Sep 4, 2021·Health Economics·Will DavisRusty Tchernis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.